January 23, 2024 10:51 AM EST
News Briefing

Mer­ck inks deal with Un­nat­ur­al Prod­ucts; CG On­col­o­gy’s up­sized IPO; Lo­cus gets $24M from BAR­DA

ENDPOINTS

Plus, news about Out­look Ther­a­peu­tics and Adicet Bio:

Mer­ck and Un­nat­ur­al Prod­ucts col­lab­o­rate: Per the deal, Mer­ck will make an undis­closed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times